Solana Company
NASDAQ:HSDTMedical - Devices
+$0.01 today
- Market cap
- $96.92M
- Beta
- 1.03
- P/E (TTM)
- -0.9
- EPS (TTM)
- -$1.78
Volume 0.86M
Average 0.38M
Returns on capital
Solana Company management
Start with the returns management earns on the capital it controls, then review the people, their trades, and growth quality.
Return Metrics
ROE, ROIC & ROA over time
ROE
-13.6%
avg 3713.6%
ROIC
-7.0%
avg -5052.6%
ROA
-13.5%
avg -224.9%
Analysis
ROIC is currently the strongest return metric at -7.0% versus its period average of -5052.6%. 0 of 3 return metrics are above their quality threshold, which helps indicate how efficiently the company turns capital and assets into profit.
Leadership
Who runs the company?
Review the executive team, tenure, compensation, and ownership.
Management
Key executives, compensation & ownership
| Name | Title | Compensation | Age | Shares Owned | Ownership % |
|---|---|---|---|---|---|
Choon Wee Chee | CEO, President & Chairman | USD 305.69K | 54 | 923.00K | 1.58% |
Agustina Gani Tjandrasuwita | COO, CFO, Treasurer & Secretary | — | 50 | 88.82K | 0.15% |
Compensation is shown in the reported currency; data updated Nov 7, 2026.
Ownership uses each executive's latest SEC Form 4 holding only when the full name maps to one reporting CIK; latest matched holding Aug 21, 2026.
Insider trading
Are insiders buying or selling?
Follow recent insider purchases and sales reported on Form 4.
Insider Trading
SEC Form 4 transactions — last 12 months
No open-market purchases or sales in the last 12 months.
Growth analysis
Is management growing the business?
Compare historical growth with analyst forecasts across revenue, earnings, and cash flow.
Growth Analysis
Historical CAGR & forward analyst estimates
| Metric | 10yr | 5yr | 3yr | Fwd Est. |
|---|---|---|---|---|
| EPS | N/A | N/A | N/A | N/A1 analysts |
| Revenue | N/A | N/A | +97.0% | +25.5% (3yr)1 analysts |
| Net Income | N/A | N/A | N/A | N/A1 analysts |
| EBIT | N/A | N/A | N/A | N/A1 analysts |
Analysis
Recent growth has been strongest in Revenue at +97.0% over three years. Forward estimates point to Revenue at +25.5% (3yr), giving you a quick check on whether expectations are accelerating or cooling.
Competitors
Who does Solana Company compete with?
Open similar companies to compare how their management teams allocate capital.
Competitors
Peer companies in the same sector
Questions
Management questions
Common questions about HSDT's management, answered from reported figures.
Who manages HSDT?
Solana Company (HSDT) lists 2 active executives. The top listed executive is Choon Wee Chee, CEO, President & Chairman.
Are HSDT insiders buying or selling?
Recent insider activity shows net buying of $17.57M.
Continue the stock analysis
Jump to another research area for this company.